TLDRs;
- IBM shares gained over 3% as investors positioned ahead of the company’s Q2 earnings report.
- Bank of America raised its IBM price target to $330, citing AI, software, and cash flow strength.
- Strong software growth, Red Hat momentum, and Confluent integration remain key drivers for IBM’s outlook.
- IBM’s July 22 earnings and guidance could determine whether the stock extends its recent rally.
International Business Machines (IBM) shares extended their recent momentum on Monday, climbing more than 3% as Wall Street grew increasingly optimistic ahead of the company’s upcoming second-quarter earnings report.
The rally came after Bank of America (BofA) raised its price target on the technology giant, citing improving software performance, AI-driven demand, and stronger free cash flow prospects.
The stock closed at $299.52, up 3.45% for the day, marking its sixth consecutive daily gain. The advance outperformed the broader market, with IBM beating the gains recorded by both the S&P 500 and the Dow Jones Industrial Average. Despite the recent rally, shares remain below their 52-week high of $332.46 reached in June.
International Business Machines Corporation, IBM
Analysts Raise Confidence Ahead
Much of Monday’s optimism was fueled by Bank of America’s latest research note, which increased its price target on IBM from $315 to $330 while maintaining a Buy rating.
The investment bank believes IBM is well positioned to deliver a solid quarterly performance when it reports earnings later this month. Rather than focusing solely on the company’s quantum computing announcements, analysts pointed to improving fundamentals across IBM’s software portfolio, particularly following its Confluent acquisition and continued expansion of Red Hat.
Bank of America also expects IBM’s free cash flow outlook to improve, supporting a richer valuation multiple than the company has historically commanded.
Bank of America’s updated forecasts call for IBM to generate approximately $18.0 billion in second-quarter revenue and adjusted earnings of $3.05 per share. Looking further ahead, the firm now expects IBM to deliver $71.4 billion in full-year 2026 revenue and earnings per share of $12.47. Analysts also project that the recently acquired Confluent business could contribute about $340 million during the quarter, making the pace of its integration into IBM’s software portfolio a closely watched factor when the company reports earnings.
AI Continues Driving Growth
Artificial intelligence continues to strengthen IBM’s long-term investment narrative.
During its previous quarterly results, IBM reported 9% year-over-year revenue growth, supported by double-digit expansion in its software business. Software revenue increased 11%, while infrastructure revenue rose 15%, highlighting balanced growth across multiple business segments.
IBM also generated $2.2 billion in free cash flow during the first quarter, reinforcing management’s confidence in achieving its longer-term financial targets.
Chief Executive Officer Arvind Krishna previously described AI as an important growth engine for the company, noting that enterprise demand for AI-powered solutions continues to expand across industries.
Investors will now be watching whether management raises its full-year outlook during the July earnings report. Any improvement to revenue or free cash flow guidance could further strengthen the bullish case presented by Bank of America.
Wall Street’s optimism reflects growing confidence that IBM’s investments in hybrid cloud computing, AI software, and enterprise infrastructure are translating into stronger financial performance.
Quantum Research Adds Momentum
While software remains the primary driver behind analyst upgrades, IBM also attracted attention after unveiling new quantum computing research.
The company announced that researchers from IBM, Oak Ridge National Laboratory, and Cleveland Clinic successfully used quantum computing to model several molecular structures associated with materials relevant to future fusion energy production.
According to IBM, the research demonstrates that quantum computing is increasingly becoming a practical scientific tool capable of solving complex real-world problems rather than remaining purely experimental.
Although investors welcomed the announcement, market analysts generally believe Monday’s stock rally reflected improving earnings expectations rather than excitement surrounding quantum technology alone.
Trading volume reached roughly 7.17 million shares, slightly below the company’s recent average, suggesting institutional investors may still be waiting for the earnings report before making larger portfolio adjustments.
Earnings Could Determine Next Move
Despite the recent gains, IBM now trades only slightly below Wall Street’s average 12-month price target of approximately $303, meaning much of the near-term optimism may already be reflected in the share price.
However, several analysts remain considerably more bullish. Besides Bank of America’s $330 target, Wedbush continues to maintain one of the highest forecasts on the stock at $350, reflecting confidence that IBM’s AI strategy and software transformation can generate sustained earnings growth.
Not every analyst shares that optimism. Some firms continue to maintain more cautious outlooks, suggesting investors should wait for clearer evidence that revenue growth and profitability can accelerate over the coming quarters.
IBM is expected to report its second-quarter earnings around July 22, a release that many investors view as the next major catalyst for the stock.
Should management raise its financial guidance while demonstrating continued momentum in AI, software, and free cash flow generation, IBM could strengthen the bullish narrative surrounding its enterprise technology transformation. Conversely, maintaining existing forecasts without significant upside could temper recent enthusiasm after the stock’s six-session winning streak.


